Metabolic and Immunological Phenotyping in Patients With Cancer

Inclusion Criteria: * Have given written informed consent to participate * Be aged 18 years or over at the time of signing the informed consent form * Have a histological or cytological diagnosis of a non-haematological cancer * Are willing and able to comply with study procedures and visits Exclusion Criteria: * Active infection, as determined by the investigator based on clinical symptoms and / or fever and / or requirement for antibiotics * Current treatment with chemotherapy, oral steroids or other immunosuppressive drugs (within 7 days of baseline investigations or during the study phase) * Significant acute, chronic or psychiatric condition or laboratory abnormality which in the judgment of the investigator would place the patient at undue risk or interfere with the study. * Intolerance to dairy products * Women, who are pregnant, plan to become pregnant or are lactating